538 related articles for article (PubMed ID: 18461922)
21. Falcipains and other cysteine proteases of malaria parasites.
Rosenthal PJ
Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
[TBL] [Abstract][Full Text] [Related]
22. Regulatory elements within the prodomain of Falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum.
Pandey KC; Barkan DT; Sali A; Rosenthal PJ
PLoS One; 2009 May; 4(5):e5694. PubMed ID: 19479029
[TBL] [Abstract][Full Text] [Related]
23. Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells.
Dhawan S; Dua M; Chishti AH; Hanspal M
J Biol Chem; 2003 Aug; 278(32):30180-6. PubMed ID: 12775709
[TBL] [Abstract][Full Text] [Related]
24. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
[TBL] [Abstract][Full Text] [Related]
25. Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entity.
Gibbons P; Verissimo E; Araujo NC; Barton V; Nixon GL; Amewu RK; Chadwick J; Stocks PA; Biagini GA; Srivastava A; Rosenthal PJ; Gut J; Guedes RC; Moreira R; Sharma R; Berry N; Cristiano ML; Shone AE; Ward SA; O'Neill PM
J Med Chem; 2010 Nov; 53(22):8202-6. PubMed ID: 20979352
[TBL] [Abstract][Full Text] [Related]
26. Exploring the role of putative active site amino acids and pro-region motif of recombinant falcipain-2: a principal hemoglobinase of Plasmodium falciparum.
Kumar A; Dasaradhi PV; Chauhan VS; Malhotra P
Biochem Biophys Res Commun; 2004 Apr; 317(1):38-45. PubMed ID: 15047145
[TBL] [Abstract][Full Text] [Related]
27. Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.
Micale N; Kozikowski AP; Ettari R; Grasso S; Zappalà M; Jeong JJ; Kumar A; Hanspal M; Chishti AH
J Med Chem; 2006 Jun; 49(11):3064-7. PubMed ID: 16722625
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M
J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
[TBL] [Abstract][Full Text] [Related]
31. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
32. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity.
Khanye SD; Smith GS; Lategan C; Smith PJ; Gut J; Rosenthal PJ; Chibale K
J Inorg Biochem; 2010 Oct; 104(10):1079-83. PubMed ID: 20621360
[TBL] [Abstract][Full Text] [Related]
34. Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.
Micale N; Ettari R; Schirmeister T; Evers A; Gelhaus C; Leippe M; Zappalà M; Grasso S
Bioorg Med Chem; 2009 Sep; 17(18):6505-11. PubMed ID: 19709887
[TBL] [Abstract][Full Text] [Related]
35. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
36. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials.
Praveen Kumar S; Gut J; Guedes RC; Rosenthal PJ; Santos MM; Moreira R
Eur J Med Chem; 2011 Mar; 46(3):927-33. PubMed ID: 21295887
[TBL] [Abstract][Full Text] [Related]
38. Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon.
Boyom FF; Kemgne EM; Tepongning R; Ngouana V; Mbacham WF; Tsamo E; Zollo PH; Gut J; Rosenthal PJ
J Ethnopharmacol; 2009 Jun; 123(3):483-8. PubMed ID: 19442463
[TBL] [Abstract][Full Text] [Related]
39. Falcipain-2 inhibition by suramin and suramin analogues.
Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
[TBL] [Abstract][Full Text] [Related]
40. Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors.
Bova F; Ettari R; Micale N; Carnovale C; Schirmeister T; Gelhaus C; Leippe M; Grasso S; Zappalà M
Bioorg Med Chem; 2010 Jul; 18(14):4928-38. PubMed ID: 20598553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
